Status:
UNKNOWN
Intravenous Iron in Patients With Anemia of Chronic Kidney Disease
Lead Sponsor:
University Hospital Muenster
Conditions:
Kidney Failure, Chronic
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The objective of this study is the evaluation of the efficacy and safety of intravenous iron sucrose in anemic patients with chronic kidney disease not on renal replacement therapy.
Detailed Description
This is a randomized, open label, phase IV study in anemic predialysis patients (Hb between 8 and 11.5 g/dl) who require iron supplementation. The duration of the study for each patient will be approx...
Eligibility Criteria
Inclusion
- Chronic kidney disease Anemia (Hb 8 - 11.5 g/dl) Age above 18 years Signed informed consent
Exclusion
- Rapid progression of kidney disease Need for dialysis Uncontrolled hypertension
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT00204256
Start Date
March 1 2004
End Date
March 1 2005
Last Update
September 20 2005
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Muenster
Münster, Westphalia, Germany, 48149